通络熄风汤治疗阴虚型缺血性脑卒中临床研究
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Clinical Study on Tongluo Xifeng Tang for Ischemic Stroke of Yin-deficiency Type
  • 作者:魏玉玲 ; 刘松年 ; 席佳佳
  • 英文作者:WEI Yuling;LIU Songnian;XI Jiajia;
  • 关键词:缺血性脑卒中 ; 阴虚型 ; 中西医结合疗法 ; 通络熄风汤
  • 英文关键词:Ischemic stroke;;Yin-deficiency type;;Integrated Chinese and western medicine therapy;;Tongluo Xifeng tang
  • 中文刊名:REND
  • 英文刊名:Journal of New Chinese Medicine
  • 机构:河南科技大学第一附属医院;
  • 出版日期:2019-03-05
  • 出版单位:新中医
  • 年:2019
  • 期:v.51;No.538
  • 语种:中文;
  • 页:REND201903036
  • 页数:4
  • CN:03
  • ISSN:44-1231/R
  • 分类号:130-133
摘要
目的:观察通络熄风汤联合西药治疗阴虚型缺血性脑卒中的临床疗效。方法:将88例阴虚型缺血性脑卒中患者按照入院顺序排序,根据奇偶数字法将其随机分为研究组和对照组,各44例;对照组采用西医常规治疗,研究组在对照组的基础上加用通络熄风汤治疗,2组均以10天为1疗程,共治疗2疗程,观察比较2组中医证候积分疗效、格拉斯哥-庇斯布赫昏迷分度表评分(G-PCS)、美国国立卫生院神经功能缺损评分(NIHSS),检测血清纤维蛋白原水平、同型半胱氨酸、β-内啡肽水平。结果:中医证候积分疗效总有效率研究组为88.64%,对照组为65.91%,2组比较,差异有统计学意义(P <0.05)。治疗前2组G-PCS、NIHSS评分无明显差异(P> 0.05);治疗后,研究组G-PCS评分明显高于对照组、NIHSS评分明显低于对照组,差异均有统计学意义(P <0.05)。治疗前,2组血清纤维蛋白原、同型半胱氨酸、血清β-内啡肽水平均处于一个较高水平,且组间比较,差异无统计学意义(P> 0.05);治疗后,研究组上述各项指标均明显低于对照组,差异有统计学意义(P <0.05)。结论:通络熄风汤联合西药治疗阴虚型缺血性脑卒中疗效显著,能显著改善患者神经功能和肢体活动功能,恢复血清学指标,促进病情康复。
        Objective:To observe the clinical effect of Tongluo Xifeng tang combined with western medicine for ischemic stroke of yin-deficiency type. Methods:A total of 88 cases of patients with ischemic stroke of yin-deficiency type were divided into the study group and the control group by the odd-even number grouping method according to the order of admission,44 cases in each group. The control group was treated with routine western medicine,and the study group was additionally treated with Tongluo Xifeng tang based on the treatment of the control group. Both groups were treated with two courses,10 days being a course. The curative effect of Chinese medicine syndrome score,score of Glasgow-Pittsburgh coma scale(G-PCS),and score of National Institute of Health Stroke Scale(NIHSS) in both groups were observed and compared. The level of fibrinogen,homocysteine and β-endorphin in serum in both groups were detected. Results:The total effective rate of the curative effect of Chinese medicine syndrome score was 88.64% in the study group and 65.91% in the control group,the difference being significant(P < 0.05). Before treatment,no significant difference was found in the comparisons of the scores of G-PCS and NIHSS between the two groups(P > 0.05). After treatment,the score of G-PCS in the study group was obviously higher than that in the control group,and the score of NIHSS in the study group was obviously lower than that in the control group,differences being significant(P < 0.05). Before treatment,the levels of fibrinogen,homocysteine and β-endorphin in serum in the two groups were at a high level,and there was no significant difference being found between the two groups(P > 0.05). After treatment,the above indexes in the study group were obviously lower than those in the control group,the difference being significant(P < 0.05). Conclusion:The therapy of Tongluo Xifeng tang combined with western medicine has significant curative effect in treating ischemic stroke of yin-deficiency type,which can significantly improve the neurological function and the limb function,restore the serum index and promote the recovery of disease.
引文
[1]叶普法,柯宁珠.通络熄风汤联合西医基础治疗对缺血性脑卒中急性期的疗效观察[J].中国中医药科技,2016,23(2):202-203.
    [2]蔡天进.通络熄风方联合依达拉奉治疗糖尿病合并急性脑卒中临床观察[J].中国中医急症,2016,25(1):152-154.
    [3]马建波,徐霞.通络熄风方加减辨治老年糖尿病合并急性脑卒中[J].吉林中医药,2017,37(2):133-136.
    [4]中华神经科学会,中华神经外科学会.各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380.
    [5]中华中医药学.中医内科常见病诊疗指南·西医疾病部分[M].北京:中国中医药出版社,2008:258-264.
    [6]国家中医药管理局脑病写作组.中风病诊断与疗效评定标准[J].北京中医药大学学报,1996,19(1):55.
    [7]黄任锋,石青,吕小亮,等.通络熄风汤联合西医基础治疗对缺血性脑卒中急性期的临床疗效观察及其安全性评价[J].广州医药,2016,47(1):73-75.
    [8]贾盛豪,王生力,吴颖华,等.通络熄风汤联合西医基础治疗对缺血性脑卒中急性期的疗效观察[J].中西医结合研究,2017,9(3):138-139,141.
    [9]赵少忠,康珊.熄风通络颗粒联合经皮穴位电刺激对脑卒中患者肢体功能、神经功能的影响[J].实用心脑肺血管病杂志,2016,24(3):90-92.
    [10]陈雪,李振海.中医药治疗脑卒中后吞咽障碍研究进展[J].河南中医,2016,36(7):1290-1293.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700